| Damron, Timothy A |
| Active, not recruiting | N/A | 245 | Canada, US | | Beth Israel Deaconess Medical Center | Cancer Bone, Bone Tumors | 12/25 | 12/25 | | |
| Recruiting | N/A | 300 | US | CERAMENT BVF | BONESUPPORT AB | Orthopedic Disorder | 03/25 | 03/25 | | |
| Enrolling by invitation | N/A | 50 | US | Control Group, CT Scan, DEXA Scans, CT and DEXA Scans | State University of New York - Upstate Medical University | Soft Tissue Sarcoma Adult | 04/25 | 04/25 | | |
| Lavelle, William F |
NCT04125147: Clinical Investigation of MONTAGE in Adults With Spinal Deformity Undergoing Pedicle Subtraction Osteotomy |
|
|
| Terminated | N/A | 5 | US | Experimental: Montage Bone Hemostat | Abyrx, Inc. | Fused Vertebrae, Ankylosing Spondylitis, Sagittal Deformities, Thoracolumbar Kyphosis | 07/23 | 07/23 | | |
NCT03118505: A Study of Infuse® Bone Graft With Mastergraft® Strip and Posterior Fixation for Posterolateral Fusion (PLF) Treatment of Multi-Level Degenerative Lumbosacral Spinal Conditions |
|
|
| Active, not recruiting | N/A | 100 | US | Infuse Bone Graft, Medtronic DBM | Medtronic Spinal and Biologics | Multi-Level Degenerative Lumbosacral Spinal Conditions | 04/26 | 12/26 | | |
| Recruiting | N/A | 200 | US | Lumbar Interbody Fusion | 3Spine, MCRA | Lumbar Spine Degeneration | 05/24 | 08/26 | | |
NCT05438719: MOTUS Total Joint Replacement Investigational Device Exemption Study |
|
|
| Active, not recruiting | N/A | 158 | US | MOTUS Total Joint Replacement | 3Spine | Lumbar Spine Degeneration | 06/25 | 06/28 | | |
| Baumann, Michael |
| Not yet recruiting | 3 | 360 | US | Buprenorphine, Zubsolv | Yale University, National Drug Abuse Treatment Clinical Trials Network, The Emmes Company, LLC, National Institute on Drug Abuse (NIDA), Alameda Health System | Opioid Use Disorder | 04/27 | 12/28 | | |
CLL17, NCT04608318 / 2019-003854-99: Ibrutinib Monotherapy Versus Fixed-duration Venetoclax Plus Obinutuzumab Versus Fixed-duration Ibrutinib Plus Venetoclax in Patients With Previously Untreated Chronic Lymphocytic Leukaemia (CLL) |
|
|
| Active, not recruiting | 3 | 897 | Europe, RoW | Ibrutinib, Imbruvica, Venetoclax, ABT-199, Venclyxto, Obinutuzumab, GA101, Gazyvaro | German CLL Study Group, Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON), Nordic CLL Study Group (NCLLSG), Swiss Group for Clinical Cancer Research (SAKK), Cancer Trials Ireland, Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA), Grupo Español de Leucemia Linfocítica Crónica (GELLC), The Israeli CLL Study Group (ICLLSG) | Chronic Lymphoid Leukemia | 03/27 | 03/27 | | |
NCT04225598: Emergency Department-Initiated Buprenorphine Validation Network Trial |
|
|
| Active, not recruiting | 2 | 2000 | US | CAM2038, Buprenorphine Sublingual Product | Yale University, National Drug Abuse Treatment Clinical Trials Network, The Emmes Company, LLC, Harvard Medical School (HMS and HSDM), University of Pennsylvania, NYU Langone Health, Icahn School of Medicine at Mount Sinai, Alameda Health System, Weill Medical College of Cornell University, National Institute on Drug Abuse (NIDA) | Opioid-use Disorder | 11/24 | 12/24 | | |
| Recruiting | N/A | 146 | Europe | Radiotherapy with protons, Radiotherapy with photons | Technische Universität Dresden, German Consortium for Translational Cancer Research, National Center for Radiation Research in Oncology Dresden/Heidelberg, Radiation Oncology Working Group of the German Cancer Society | Prostate Cancer | 02/24 | 02/26 | | |
| Sima, Jody |
NCT03543852: SurvivorLink: Scalability of an Electronic Personal Health Record |
|
|
| Active, not recruiting | N/A | 1800 | US | SurvivorLink | Emory University, National Cancer Institute (NCI) | Childhood Cancer | 12/24 | 12/24 | | |
